Seagen's Cancer Therapy Is Making It a Takeover Target
The unprofitable biotech that pioneered novel cancer agents has caught the attention of the world’s largest drugmakers.
The unprofitable biotech that pioneered novel cancer agents has caught the attention of the world’s largest drugmakers.